Strongbridge Biopharma plc - Ordinary Shares (SBBP): Price and Financial Metrics


Strongbridge Biopharma plc - Ordinary Shares (SBBP)

Today's Latest Price: $2.74 USD

0.03 (1.11%)

Updated Dec 2 4:00pm

Add SBBP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SBBP Stock Summary

  • For SBBP, its debt to operating expenses ratio is greater than that reported by just 11.57% of US equities we're observing.
  • In terms of twelve month growth in earnings before interest and taxes, Strongbridge Biopharma plc is reporting a growth rate of -184.61%; that's higher than just 10.76% of US stocks.
  • As for revenue growth, note that SBBP's revenue has grown 36.33% over the past 12 months; that beats the revenue growth of 86.69% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Strongbridge Biopharma plc, a group of peers worth examining would be ATEN, CAMT, DIOD, INVE, and AEHR.
  • SBBP's SEC filings can be seen here. And to visit Strongbridge Biopharma plc's official web site, go to www.strongbridgebio.com.

SBBP Stock Price Chart Interactive Chart >

Price chart for SBBP

SBBP Price/Volume Stats

Current price $2.74 52-week high $4.63
Prev. close $2.71 52-week low $1.50
Day low $2.67 Volume 268,600
Day high $2.84 Avg. volume 461,083
50-day MA $2.27 Dividend yield N/A
200-day MA $2.86 Market Cap 184.25M

Strongbridge Biopharma plc - Ordinary Shares (SBBP) Company Bio


Strongbridge Biopharma PLC is focused on the development, in-licensing, acquisition and eventual commercialization of complementary product candidates across multiple franchises that target rare diseases. The company was founded in 1996 and is based in Trevose, Pennsylvania.


SBBP Latest News Stream


Event/Time News Detail
Loading, please wait...

SBBP Latest Social Stream


Loading social stream, please wait...

View Full SBBP Social Stream

Latest SBBP News From Around the Web

Below are the latest news stories about Strongbridge Biopharma plc that investors may wish to consider to help them evaluate SBBP as an investment opportunity.

Insider Buys Strongbridge Biopharma's Stock

Shares of Strongbridge Biopharma Inc (NASDAQ:SBBP) increased by 2.4% from the previous closing price. Gill David N filed a Form 4 with the SEC on Monday, …

Benzinga | September 28, 2020

Strongbridge Bio raises $25M by public offering

Strongbridge Biopharma (SBBP) has priced its public offering of ~11.1M ordinary shares at $2.25/share for total gross proceeds of ~$25M.Underwriters' over-allotment is an additional ~1.67M shares. Net proceeds will be used for development and commercialization of Recorlev in U.S., support the life cycle management activities of Keveyis and other general...

Seeking Alpha | September 17, 2020

Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares

DUBLIN, Ireland and TREVOSE, Pa., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (NASDAQ:SBBP), a global commercial-stage biopharmaceutical …

Benzinga | September 16, 2020

Will Strongbridge Biopharma (SBBP) Report Negative Q2 Earnings? What You Should Know

Strongbridge Biopharma (SBBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 22, 2020

Strongbridge Biopharma plc Announces Appointment of John H. Johnson to Chief Executive Officer

Strongbridge Biopharma plc, (SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that at the request of the Board of Directors, John H. Johnson has agreed to become the chief executive officer (CEO) of Strongbridge. Mr. Johnson, who has served as chairman of Strongbridge since March 2015, assumed the position of executive chairman in November 2019 to lead the organization while the Board conducted a formal search to identify a new CEO.

Yahoo | July 7, 2020

Read More 'SBBP' Stories Here

SBBP Price Returns

1-mo 40.51%
3-mo -24.10%
6-mo -22.16%
1-year 49.73%
3-year -59.41%
5-year -53.40%
YTD 31.10%
2019 -53.35%
2018 -38.21%
2017 202.08%
2016 -68.42%
2015 N/A

Continue Researching SBBP

Here are a few links from around the web to help you further your research on Strongbridge Biopharma plc's stock as an investment opportunity:

Strongbridge Biopharma plc (SBBP) Stock Price | Nasdaq
Strongbridge Biopharma plc (SBBP) Stock Quote, History and News - Yahoo Finance
Strongbridge Biopharma plc (SBBP) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8528 seconds.